Moreover, the combination of the two drugs did not further increase the synthetic lethality of VE-821 alone, suggesting that HRR inhibition plays a major role in the synthetic lethality in FHIT-deficient lung cancer cells (Fig. 7d). Here, FHIT is linked to lung cancer.